TOPIRAMATE CAPSULES USP

FDA approves Glenmark Topmax bioequivalent capsules

The US regulator has determined the approved Topiramate capsules USP, 15 mg and 25 mg to be bioequivalent and therapeutically equivalent to Topamax Capsules, 15 mg and 25 mg of Janssen Pharmaceuticals, Inc., and will be distributed by Glenmark in the U.S. markets.